Evidence map›Paper›PMID 38261030›Full record

ArticleJournal of neurology2024

Utility of genetic testing in the pre-surgical evaluation of children with drug-resistant epilepsy.

Sarah Alsubhi, Saoussen Berrahmoune, Roy W R Dudley, David Dufresne, Elisabeth Simard Tremblay, Myriam Srour, Kenneth A Myers

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 11 citations in OpenAlex.

  1. Genetic Diagnosis in Epilepsy: Implications for Clinical Management.Current neurology and neuroscience reports · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Observational
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sarah AlsubhiDivision of Child Neurology, Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, QC, Canada.
Saoussen BerrahmouneChild Health and Human Development Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Roy W R DudleyChild Health and Human Development Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
David DufresneDivision of Child Neurology, Department of Pediatrics, University of Sherbrooke, Sherbrooke, QC, Canada.
Elisabeth Simard TremblayDivision of Child Neurology, Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, QC, Canada.
Myriam SrourDivision of Child Neurology, Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, QC, Canada.
Kenneth A MyersDivision of Child Neurology, Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, QC, Canada. kenneth.myers@mcgill.ca.ORCID http://orcid.org/0000-0001-7831-4593
Montreal Children's Hospital · CAMcGill University Health Centre · CAUniversité de Sherbrooke · CA

Funding

Fonds de Recherche du Québec - Santé 282228Fonds de Recherche du Québec - Santé 295639
6 · The paper itself

Abstract

We evaluated the utility of genetic testing in the pre-surgical evaluation of pediatric patients with drug-resistant focal epilepsy. This single-center retrospective study reviewed the charts of all pediatric patients referred for epilepsy surgery evaluation over a 5-year period. We extracted and analyzed results of genetic testing as well as clinical, EEG, and neuroimaging data. Of 125 patients referred for epilepsy surgical evaluation, 86 (69%) had some form of genetic testing. Of these, 18 (21%) had a pathogenic or likely pathogenic variant identified. Genes affected included NPRL3 (3 patients, all related), TSC2 (3 patients), KCNH1, CHRNA4, SPTAN1, DEPDC5, SCN2A, ARX, SCN1A, DLG4, and ST5. One patient had ring chromosome 20, one a 7.17p12 duplication, and one a 15q13 deletion. In six patients, suspected epileptogenic lesions were identified on brain MRI that were thought to be unrelated to the genetic finding. A specific medical therapy choice was allowed due to genetic diagnosis in three patients who did not undergo surgery. Obtaining a molecular diagnosis may dramatically alter management in pediatric patients with drug-resistant focal epilepsy. Genetic testing should be incorporated as part of standard investigations in the pre-surgical work-up of pediatric patients with drug-resistant focal epilepsy.

Indexed as

Drug Resistant EpilepsyGenetic TestingAdolescentChildChild, PreschoolElectroencephalographyEpilepsies, PartialFemaleHumansInfantMagnetic Resonance ImagingMalePreoperative CareRetrospective StudiesCHRNA4Drug-resistant epilepsyEpilepsy surgeryGenetic testingNPRL3SCN2A

Identifiers

PMID38261030
OpenAlexW4391135291

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.